Exploratory comparisons between different anti-mitotics in clinically-used drug combination in triple negative breast cancer

Triple-negative breast cancer (TNBC) constitutes a very aggressive type of breast cancer with few options of cytotoxic chemotherapy available for them. A chemotherapy regimen comprising of doxorubicin hydrochloride and cyclophosphamide, followed by paclitaxel, known as AC-T, is approved for usage as...

Full description

Main Authors: Guido, Bruna Cândido, Brandão, Douglas Cardoso, Barbosa, Ana Luisa Augusto, Vianna, Monique Jacob Xavier, Faro, Lucas, Ramos, Luciana Machado, Nihi, Fabíola, Castro, Márcio Botelho de, Neto, Brenno A. D., Corrêa, José Raimundo, Báo, Sônia Nair
Format: Artigo
Language: Inglês
Published: Oncotarget 2021
Subjects:
Online Access: https://repositorio.unb.br/handle/10482/42548
https://doi.org/10.18632/oncotarget.28068
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items